The 2011 Call for Session Proposals – Educational Track released by convention.bio.org gives an insight into the issues facing the biotech industry.
The impact of regulatory and compliance requirements on the ability of the biotechnology industry to research and develop healthcare products is one major issue. In addition to R&D, marketing is also affected by regulations, not only of FDA of the U.S. but also of regulatory bodies in other countries.
Developing eco-friendly alternative solutions, in the forms of new materials and cleaner manufacturing processes is another issue. Bio-based products from biomass, biofuels and food ingredients are examples and the issues involved with each of these solutions need to be explored in detail. For example, the once promising biofuel is facing criticism on the ground that it reduces the availability of food crops in a world where a large number of people do not get adequate food.
Detection, prevention, diagnosis and treatment of diseases are helped by developing, validating and qualifying biological markers. Personalized medicine that decides the best treatment for each individual based on the person’s genetic characteristics is another area of major significance.
Intellectual property protection, global biotech licensing, technology transfer, and collaborations is another key issue for the industry. So is a clear picture of emerging trends in business development through partnering and alliances.
Read more by downloading the document from convention.bio.org website.
